EU drugs watchdog begins review of Moderna’s variant COVID vaccine
The US-based Moderna's so-called bivalent vaccine targets two strains of the SARS-CoV-2 virus behind COVID, the original strain…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
COVID-19 Updates
Omnicron less likely to cause long COVID: UK Study
Researchers at King's College London found the odds of developing long COVID after infection were 20 per cent to 50 per cent lower…
ICMR study finds Covaxin booster dose improves effectiveness against Delta, Omicron variants
The antibody response, clinical observations, viral load reduction and lung disease severity after virus challenge were observed…
Sputnik V is 97% effective against hospitalisation due to Omicron after revaccination with Sputnik…
The study was conducted from 11 January to 21 February 2022 involving over 1,000 patients in Moscow
J&J gives notice to terminate Emergent manufacturing deal for COVID vaccine
The termination notice comes about a week after J&J had initially informed Emergent of its intent to end the pact based on the…
Pfizer to spend $120 million to boost US COVID pill manufacturing
Use of the pill, Paxlovid, authorised to treat newly infected, at-risk people to prevent severe illness, has soared recently as…
Novavax says COVID vaccine for US to be manufactured by SII
"All vaccines that are being distributed globally commercially are being made in a single facility by our partners (the Serum…
IISc scientists develop miniproteins that may prevent COVID infection
The team used this approach to design miniproteins that can bind to, and block the spike protein on the surface of the SARS-CoV-2…
Corbevax gets DCGI nod as heterologous COVID-19 booster dose
It is the first vaccine in India to get DCGI approval for a heterologous COVID-19 booster shot
Immune modulator drugs improves survival for people hospitalised with COVID-19
NIH launched the ACTIV-1 immune modulators clinical trial to determine if certain drugs that help minimise the effects of an…
Researchers devise age-based eligibility method to measure vaccine effectiveness in data-deficient…
The team exploits the fact that many governments applied age-based eligibility cut-offs when rolling out their vaccination…
Japan study shows women more likely to get skin rash from Moderna shot
The study of 5,893 participants between May and November last year showed that 22.4 per cent of women developed delayed skin…
Canada authorises Pfizer COVID-19 booster for 16 and 17-year-olds
The decision was based on data from two studies of the booster shot among individuals aged 16 years and older
Three doses of same or mixed jabs work equally well against COVID: Study
While the effectiveness of individual vaccines for COVID-19 are well known, the effectiveness of vaccine combinations is less…
Researchers identify rise in Guillain-Barre syndrome following AstraZeneca vaccine
Researchers at the University College London (UCL) said they are yet to understand the cause of the link
US FDA lifts hold on Covaxin’s clinical trials
The FDA's earlier decision, in April, to put on hold the trials was based on the US firm's decision to voluntarily implement a…
Pfizer/BioNTech say three COVID shots elicit good response in children under five years of age
The companies said they plan to soon ask global regulators to authorise the shot for the age group, children for whom no vaccine…
India Exim Bank-JBIC conclude $100 million loan agreement to support Indian healthcare sector…
The India Exim Bank concluded the agreement with Japan Bank for International Cooperation (JBIC), along with MUFG Bank, the Bank…
India supplies non-J&J vaccines to Cambodia and Thailand under Quad umbrella
The leaders of the Quad countries - India, the US, Japan and Australia - could discuss the vaccine supply plan when they meet in…
Dr Reddy’s Lab to approach regulator for Sputnik Light as booster dose
The Drugs Controller General of India (DCGI) in February granted approval to the single-shot Sputnik Light vaccine for restricted…